HomeRCKT • NASDAQ
add
Rocket Pharmaceuticals Inc
Previous close
$11.56
Day range
$11.21 - $11.61
Year range
$11.15 - $32.53
Market cap
1.21B USD
Avg Volume
1.32M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 69.42M | 6.11% |
Net income | -66.72M | -7.79% |
Net profit margin | — | — |
Earnings per share | -0.71 | 5.33% |
EBITDA | -67.04M | -5.29% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 235.66M | -46.09% |
Total assets | 393.69M | -34.25% |
Total liabilities | 63.92M | 10.82% |
Total equity | 329.77M | — |
Shares outstanding | 91.16M | — |
Price to book | 3.19 | — |
Return on assets | -41.32% | — |
Return on capital | -45.32% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -66.72M | -7.79% |
Cash from operations | -52.10M | 8.83% |
Cash from investing | 78.92M | 63.55% |
Cash from financing | 176.00K | -99.91% |
Net change in cash | 26.99M | -85.05% |
Free cash flow | -21.43M | 45.28% |
About
Founded
1999
Headquarters
Website
Employees
268
